Fraud Claims Against Raptiva Makers Dismissed

GRAND RAPIDS, Mich. - A Michigan federal judge has dismissed fraud claims brought against the makers of the psoriasis drug Raptiva on the basis that they allege fraud on the Food and Drug Administration, a Michigan federal judge has ruled. Blair v. Genentech Inc., et al., No. 11-482 (W.D. Mich.).

On Oct. 26, Judge Robert J. Jonker of the U.S. District Court for the Western District of Michigan ruled that the suit should be dismissed because the plaintiff claims that the drug makers failed to comply with the FDA's post-approval safety, surveillance and warning requirements.

Shay Blair, a Michigan citizen, …